முதலீட்டாளர் உறவுகள் தொடர்பு மின்னஞ்சல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BetterLife’s Recent Acquisition: Taking LSD from Experimental to a Major Therapeutic Application
BetterLife’s Recent Acquisition: Taking LSD from Experimental to a Major Therapeutic Application
VANCOUVER, Dec. 14, 2020 BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech focused on the development and commercialization of cutting edge treatments, today announced the value proposition of its acquisition of Transcend Biodynamics, LLC’s (“Transcend”) manufacturing patent “Process of synthesizing 2-Bromo-LSD.” 
While the medicalization of psychedelics is evolving and gaining momentum at an extraordinary pace, such therapeutics still face regulatory hurdles in the areas of manufacturing, formulating, and ultimately dispensing or the rescheduling of Schedule I drugs to patients. Attaining the goals of any given psychedelic-based endeavour will require the removal of federally scheduled en ....

United States , British Columbia , Patrick Kroupa , Ahmad Doroudian , Dost Mustaq , No Securities Exchange , Betterlife Pharma Inc , United Nations , Neither The Canadian Securities Exchange , Canadian Securities Exchange , International Investor Relations Contact , Transcend Biodynamics , Betterlife Pharma , American Journal , Controlled Substance , Controlled Substance Act , Chief Executive Officer , Qlife Pharma , Chief Executive Officer Email , Investor Relations Contact Email , Market Regulator , Securities Exchange , ஒன்றுபட்டது மாநிலங்களில் , பிரிட்டிஷ் கொலம்பியா , பேட்ரிக் க்ரோபா , டாஸ்ட் மஸ்டேக் ,